MedPath

se of platelet eyedrops in diabetic patients with dry eye disease.

Not Applicable
Conditions
dry eye diseasediabetes
C11.496.260
Registration Number
RBR-96t463
Lead Sponsor
Hemocentro de Alagoas-HEMOA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Diagnose of diabetes following ADA (American Diabetes Association)criteria;moderate or severe dry eye patients with unresponsiveness or a weak response to conventional treatment; having at least a frequent or constant symptom and either a Schirmer test at less than 15mm or a BUT(Break Up Time test) less than 10 seconds.

Exclusion Criteria

Individuals under 18; mentally disabled; pregnant women; indigenous people and those who are wards of the state. Patients that had keratopathies; use of glaucoma eyedrops; previous rheumatic disease diagnosis. Patients that had contraindicated conditions to be submitted to autologous donation

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath